Nursing Advocacy and Implementation of the Health Care Affordability Act of 2025
Overview
This reflection paper examines the Health Care Affordability Act of 2025 (S. 46) and its implications for nursing practice and patient care outcomes. The author advocates for nurse engagement in legislative processes at multiple governmental levels to strengthen enforcement mechanisms and address healthcare disparities through policy advocacy.
What this reflection paper covers
- Introduction to the Health Care Affordability Act of 2025 and its core provisions regarding prescription drug costs and insurance subsidies
- Senate Finance Committee markup stage as critical advocacy opportunity and nursing engagement strategies through ANA toolkit and grassroots campaigns
- Roles of legislative, executive, and judicial branches in implementation and potential challenges in regulatory compliance and CMS guidance
Preview
Support for the Health Care Affordability Act of 2025
The Health Care Affordability Act of 2025 (S. 46, 119th Congress) aims to enhance healthcare affordability by capping out-of-pocket costs for prescription drugs and medical services, expanding subsidies under the Affordable Care Act, and promoting price transparency to reduce financial burdens on patients, particularly those with chronic conditions. As a nurse, I strongly support this bill because it directly addresses barriers to care that exacerbate health disparities, allowing patients to adhere better to treatment plans and reducing emergency visits that strain nursing resources.
A critical point for political action is the Senate Finance Committee markup stage, where the bill was referred post-introduction on January 9, 2025. Advocacy here could focus on lobbying key members to amend provisions for stronger enforcement mechanisms against pharmaceutical pricing abuses, potentially swaying moderate Republicans to support passage (Congress.gov, 2025). Nurses can engage by contacting these legislators via the ANA's advocacy toolkit, testifying in committee hearings, or joining grassroots campaigns to highlight real-world impacts on patient outcomes (American Nurses Association, 2025; Short, 2021). My representatives have potential involvement because they serve in the Senate Health, Education, Labor, and Pensions (HELP) Committee, which oversees related affordability issues, positioning him to co-sponsor or advocate during floor debates.
Potential executive involvement includes HHS implementation through rulemaking to define subsidy eligibility, while judicial challenges could arise from pharmaceutical lobbies alleging overreach under the Commerce Clause, like past ACA suits.